Physician profile
Richard E Payne
NPI 1841252707
$180,725.67
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.39 · 2020: $8,141 · 2021: $1,650 · 2022: $32K · 2023: $66K · 2024: $61K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $83K · Travel and Lodging: $34K · Consulting Fee: $18K · Food and Beverage: $3,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $82,885.00 |
| Travel and Lodging | $34,140.53 |
| Consulting Fee | $18,413.50 |
| Food and Beverage | $3,910.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $158,676.79 | 2020-2025 | Veozah |
| Astellas Pharma Europe Ltd | $17,940.15 | 2024 | Padcev, Veozah |
| Allergan, INC. | $3,790.98 | 2020 | |
| Lucid Diagnostics INC. | $131.45 | 2023 | |
| Sanofi Pasteur INC. | $50.56 | 2019-2025 | |
| Terumo Bct, INC. | $37.26 | 2022 | |
| Exact Sciences Corporation | $24.86 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $23.42 | 2019 | |
| Pfizer INC. | $17.74 | 2022 | |
| Cranial Technologies, INC | $16.30 | 2019 | |
| Hologic Sales and Service, LLC | $16.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.